Literature DB >> 402630

Influence of intravenous nutrients on bilirubin transport. II. Emulsified lipid solutions.

M M Thaler, R P Wennberg.   

Abstract

The effects of an emulsified intravenous fat preparation (Intralipid) on bilirubin transport were analyzed by cholestyramine extraction, spectrophotometric analysis, Sephadex gel filtration, peroxidase assay, bilirubin uptake by red blood cells, and by toxicity in tissue culture (L-929) cells. Intralipid is capable of binding bilirubin, but does not compete effectively with bilirubin bound to high affinity sites on albumin. The emulsified fat appears to have a higher affinity for bilirubin than for cell membranes. Red blood cells become coated with Intralipid, resulting in an increased association of bilirubin with the cell surface, but a decrease in pigment actually incorporated into the red cell membrane. In tissue culture experiments, Intralipid protected the cells from bilirubin toxicity. It is concluded that Intralipid may enhance the carrying capacity of serum for bilirubin, and thus exert a protective effect on tissues.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 402630     DOI: 10.1203/00006450-197703000-00004

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  4 in total

1.  Influence of intravenous fat emulsion on serum bilirubin in very low birthweight neonates.

Authors:  Y W Brans; D A Ritter; J D Kenny; D S Andrew; E B Dutton; D W Carrillo
Journal:  Arch Dis Child       Date:  1987-02       Impact factor: 3.791

2.  Interaction of bilirubin with human erythrocyte membranes.

Authors:  H Sato; S Kashiwamata
Journal:  Biochem J       Date:  1983-02-15       Impact factor: 3.857

Review 3.  Neonatal bilirubin toxicity. A review of kernicterus and the implications of drug-induced bilirubin displacement.

Authors:  P C Walker
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

4.  Influence of clinical status on the association between plasma total and unbound bilirubin and death or adverse neurodevelopmental outcomes in extremely low birth weight infants.

Authors:  W Oh; D K Stevenson; J E Tyson; B H Morris; C E Ahlfors; G Jesse Bender; R J Wong; R Perritt; B R Vohr; K P Van Meurs; H J Vreman; A Das; D L Phelps; T Michael O'Shea; R D Higgins
Journal:  Acta Paediatr       Date:  2010-01-25       Impact factor: 2.299

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.